Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9612 posts found.

sag_ebola

Scientists develop treatment for all strains of Ebola

January 10, 2019 Research and Development Ebola, primates, research UTMB, texas, zmapp

Scientists at the University of Texas Medical Branch (UTMB) in Galveston, Texas have developed a new experimental drug that protects …
News
psm_v46_d168_mesial_view_of_the_human_brain

Commonly used heart and diabetes drugs may improve mental health, study finds

January 10, 2019 Research and Development UCL, bipolar, mental health, research, schizophrenia

Commonly used anti-cholesterol drugs, blood pressure drugs and medicines used for diabetes may improve the mental health of those with …
News
bonecells

Amgen and UCB’s Evenity approved in Japan for osteoporosis

January 9, 2019 Research and Development, Sales and Marketing Amgen, Japan, UCB Pharma, osteoporosis, pharma

Amgen has revealed that its bone-forming monoclonal antibody Evenity (romosozumab), developed in partnership with UCB Pharma, has been awarded approval …
News

Death row inmate whose execution was postponed found dead in cell

January 9, 2019 Research and Development Alvogen, Scott Dozier, execution, pharma, prison

Scott Dozier, the death row inmate whose execution was stalled by court cases launched by pharmaceutical companies, has been found …
News

Super gonorrhoea on the rise, health officials warn

January 9, 2019 Research and Development STI, gonorrehoea, health, public health, std

Health officials from Public Health England (PHE) have warned that cases of antibiotic resistant strains of the sexually transmitted infection …
News

Pfizer to shutter two manufacturing plants in India, 1,700 jobs at risk

January 9, 2019 Manufacturing and Production, Research and Development India, Pfizer, pharma

Pfizer has announced it is to shut down two of its manufacturing facilities in India – a move which could …
News
clostridium_difficile_cdc

Researchers explain link between anti-inflammatories and C. difficile

January 9, 2019 Research and Development C diff, C.Diff, Vanderbilt, anti-inflammatory, cdi, nsaids, research

In the past, observational studies have found a link between the use of common nonsteroidal anti-inflammatory drugs (NSAIDs) and increased …
News
nicola_redfern

bluebird bio reveals new UK General Manager

January 9, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bluebird Bio, appointment, pharma

bluebird bio, a US-based gene therapy biotech with a focus on cancer and severe genetic conditions,  has named Nicola Redfern …
Appointment
jose_baselga

AstraZeneca hire controversial cancer doc to head new Oncology R&D unit

January 8, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Cancer, journal, oncology

The Anglo-Swedish multinational AstraZeneca has named Dr José Baselga as the firm’s new head of research and development in oncology.The …
Appointment
heart-2372134_640

Two biomarkers can aid in atrial fibrillation screening, researchers find

January 8, 2019 Manufacturing and Production, Research and Development University of Birmingham, atrial fibrillation, biomarkers, pharma

A team of researchers at the University of Birmingham has identified a pair of biomarkers which it says could aid …
News
jallal

Immunocore names AstraZeneca exec as new CEO

January 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Clinical stage biotechnology company Immunocore has announced the appointment of AstraZeneca executive Bahija Jallal as the company’s new CEO. The …
Appointment
mark_mallon

Ironwood Pharmaceuticals names AstraZeneca veteran Mark Mallon as new CEO

January 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, CEO, Ironwood, Sweden, mark mallon

The Cambridge, Massachusetts pharma firm Ironwood Pharmaceuticals has announced the appointment of AstraZeneca veteran Mark Mallon in preparation for the …
Appointment

How tech is powering precision treatment

January 7, 2019 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Precision Medicine, pharma, tech

As the scientific community eschews scattergun approaches and demand rises for higher-quality, targeted care, Matt Fellows explores how technologies such …
Feature
shutterstock_36423250

Promising interim Phase 3 data spurs epidermolysis bullosa trial expansion for Amryt

January 7, 2019 Research and Development, Sales and Marketing Amryt, epidermolysis bullosa, pharma, rare disease

Rare disease firm Amryt has announced interim efficacy data for its epidermolysis bullosa (EB) therapy AP101, showing that things are …
News
stocks1

Aevi Genomic Medicine’s share price crashes 75% following ADHD trial failure

January 4, 2019 Medical Communications, Research and Development ADHD, AEVI-001, Aevi Genomic Medicine, clinical trial failure, pharma

Aevi Genomic Medicine, a US drugmaker based outside of Philadelphia, has seen its share value plummet by 75% following the …
News
The Gateway to Local Adoption Series

Latest content

Kayentis and RWS partner to improve clinical trial data confidence

April 17, 2026

MHRA expands its pioneering AI Airlock programme with £3.6m funding boost

April 16, 2026

Ardena opens new US bioanalytical laboratory

April 15, 2026

Gesynta Pharma doses first patient in endometriosis phase 2 trial

April 14, 2026

Astellas Pharma’s new non-hormonal menopausal hot flush treatment Veoza can be used in the NHS, NICE says

April 13, 2026